Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel
PaperCitations, authors & open-access status
Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 30 citations, 2017 year and gold oa status.
30
Citations
2017
Year
gold
OA Status